Oral Presentations

“Evaluating the performance of Claude 3.7 Sonnet in data extraction automation for systematic literature reviews (SLRs)” Chow C, Kasireddy E, Pourrahmat MM, Collet JP, Fazeli MS. ISPOR 2025, May 13-16, 2025. Link to Publication.

“The Landscape of Current Policy and Health Authority Positions on Intermediate Endpoints (IEs) for Clinical Outcomes in Oncology” Siebert U, De Solda F, Hofer K, Lam O, McCallion J, McCarthy SA, Mundle S, Pourrahmat MM, Jahn B. ISPOR 2025, May 13-16, 2025. Link to Publication.

“Economic Burden and Healthcare Resource Utilization in Sjögren’s Disease: A Systematic Literature Review.”  Choi J, Christodoulou A, Sreih A, Hofer K, Pourrahmat MM, Fazeli MS, Fisher BA. ISPOR 2024, May 5-8, 2024. Link to Publication.

“Extrapolating discrete time disease evolution data in limited series of transition probability matrices: A continuous time Markov chain approach” Behnam Sharif, Yuanhui Zhang, Nishu Gaind, Murat Kurt Kurt. 18th Biennial European Conference of SMDM, Berlin, Germany, 21-23 May 2023. Link to Publication.

“Evaluation of Surrogate Endpoints (SES) for Previously Untreated Unresectable or Metastatic Melanoma (MMEL): Analyses from a Longitudinal Electronic Health Record Database in the United States (US)” Leung L, Mohr P, Serafini P, Kanters S, Pourrahmat MM, Moshyk A, Srinivasan S, Kurt M. ISPOR 2023, May 7^th-10^th, 2023. Link to Publication.

“Disease-Free Survival (DFS) As a Surrogate Endpoint for Overall Survival (OS) in Adults with Resectable Esophageal or Gastroesophageal Junction Cancer: A Correlation Meta-Analysis” Leung L., Kurt M., Singh P., Kim I., Kanters S. Virtual ISPOR 2021, May 17^th-20^th, 2021. Link to publication.

“Impact of training and guidance on the inter-rater and inter-consensus reliability of risk of bias instruments for non-randomized studies.” Jeyaraman MM, Robson RC, Pollock M, Copstein L, Balijepalli C, Hofer K, Xia J, Al-Yousif N, Mansour S, Fazeli MS, Ansari MT, Tricco AC, Rabbani R, Abou-Setta AM. In: Advances in Evidence Synthesis: special issue Cochrane Database of Systematic Reviews 2020;(9 Suppl 1). Link to publication.

“Investigating Progression-Free Survival as a Potential Surrogate Endpoint for Overall Survival in First-Line Treatment for Glioblastoma Multiforme – A Meta-Analysis Of Randomized Controlled Trials.” Fu A, Fazeli MS, Kanters S, Siliman G, Chaudhary MA, Gogate A, Kurt M. Virtual ISPOR 2020. May 18^th-20^th, 2020. Link to publication.

“Inter-rater Reliability, Inter-consensus Reliability and Evaluator burden of ROBINS-I, and ROBINS-E: A Cross-sectional Study.” Jeyaraman MM., Rabbani R., Robson R., Copstein L., Al-Yousif N., Xia J., Pollock M., Hofer K., Balijepalli C., Mansour S., Bond K., Fazeli MS., Ansari M., Tricco A., Abou-Setta AM. The 26^th Cochrane Colloquium 2019, Santiago, Chile. October 22^nd-25^th, 2019. Link to publication.